Share General Information
Apixaban is an anti-clotting substance used to reduce the risk of stroke and systemic embolism (blood coagulation) in patients with nonvalvular atrial fibrillation (abnormal heart rhythm that is not caused by a heart valve problem).Atrial fibrillation (AF) occurs when the two upper chambers (atria) of the heart do not contract properly, allowing formation of blood clots, which can travel to other parts of the body. When a clot blocks blood flow to the heart or the brain, a heart attack or stroke can follow. Blood clots can wreak havoc in other parts of the body as well.
About the API
-
Japan DMF
-
Korea DMF
-
US DMF
Updates About Apixaban
The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.
For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.
